Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Soltysiak KA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Morita K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bravo GM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Tingen MS; Cancer Prevention, Control, & Population Health Program, Georgia Cancer Center, Augusta University, Augusta, GA; Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA., Cortes JE; Georgia Cancer Center, Augusta, GA. Electronic address: jorge.cortes@augusta.edu.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Nov; Vol. 23 (11), pp. e369-e378. Date of Electronic Publication: 2023 Aug 06.
Autor:
Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zheng H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lockyer PP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3154-3164. Date of Electronic Publication: 2022 Sep 05.
Autor:
Darbaniyan F; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX., Zheng H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Kanagal-Shamanna R; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX., Lockyer P; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Estecio M; Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, X., Lu Y; Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, X., Soltysiak KA; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Chien KS; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Yang H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Class C; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX; Department of Pharmaceutical Sciences, Butler University, Indianapolis, IN., Ganan-Gomez I; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Do KA; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Wei Y; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: ywei@mdanderson.org.
Publikováno v:
Experimental hematology [Exp Hematol] 2022 Nov; Vol. 115, pp. 44-53. Date of Electronic Publication: 2022 Sep 21.
Autor:
Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ywei@mdanderson.org., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zheng H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bao N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lockyer PP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Class CA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lu Y; Department of Epigenetic & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin K; Department of Epigenetic & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ggarciam@mdanderson.org.
Publikováno v:
Leukemia [Leukemia] 2022 Aug; Vol. 36 (8), pp. 2097-2107. Date of Electronic Publication: 2022 Jun 14.
Autor:
Thongon N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma F; Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA., Santoni A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Marchesini M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Fiorini E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rose A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Adema V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Groarke EM; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Gutierrez-Rodrigues F; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Chen S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lockyer P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schneider S; Department of Stem Cell Transplantation and Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Cancer Center, Houston, TX, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Class CA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, USA., Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pellegrini M; Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA, USA., Sahin E; Huffington Center On Aging, Baylor College of Medicine, Houston, TX, USA., Bertuch AA; Department of Pediatrics and Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Young NS; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Dwyer K; Department of Stem Cell Transplantation and Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. SColla@mdanderson.org.
Publikováno v:
Nature communications [Nat Commun] 2021 Nov 25; Vol. 12 (1), pp. 6850. Date of Electronic Publication: 2021 Nov 25.
Autor:
Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kim K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nogueras-Gonzalez GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sheppard KB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Klingner-Winton C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dong XQ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2021 Nov; Vol. 195 (3), pp. 378-387. Date of Electronic Publication: 2021 Aug 02.